Literature DB >> 15690665

Flat-type early colorectal cancer preferentially develops in right-sided colon in older patients.

Makoto Okamoto1, Takao Kawabe, Yutaka Yamaji, Jun Kato, Tsuneo Ikenoue, Gouichi Togo, Hirotsugu Watabe, Haruhiko Yoshida, Yasushi Shiratori, Masao Omata.   

Abstract

BACKGROUND: Flat-type colorectal cancer is frequently reported in Japan and Europe, but its clinical features remain obscure. Thus, we investigated the clinical features of flat-type early colorectal cancer with respect to tumor location and patient age and compared them with those of polypoid-type early and advanced cancer.
METHODS: Between January 1999 and June 2001, total colonoscopy was performed in 6,178 patients (mean age, 61 years; 4,290 males and 1,888 females). Of these patients, 402 patients with 429 colorectal cancers were found: 202 at advanced stage (invading beyond muscularis propria) and 227 at early stage (carcinoma in situ or invading within submucosa). Early-stage cancer was classified into two macroscopic subgroups: flat-type and polypoid-type.
RESULTS: Out of 227 early cancers, 44 were flat type and 183 were polypoid. Flat-type early cancer was more frequently located in the right colon (57 percent, 25/44) than polypoid-type cancer (19 percent, 35/183; P < 0.001). Adenomatous component in flat-type early cancer was less frequent than in polypoid-type cancer (23 percent vs. 92 percent, P < 0.001). The proportion of right-sided colon in flat-type early cancer increased with age (33 percent in patients < or = 59 years, 50 percent in patients between 60 and 69 years, and 72 percent in patients > or = 70 years), whereas polypoid-type early cancer showed minimal change (16 percent, 18 percent, and 25 percent, respectively). An increase in the proportion of right-sided colon with age was also found in advanced cancer (20 percent, 38 percent, and 52 percent, respectively).
CONCLUSION: The incidence of flat-type early cancer in right-sided colon increased with age, similar to the pattern of advanced cancer. This suggests that flat-type early cancer may be a precursor of advanced cancer in the right colon, especially in older people.

Entities:  

Mesh:

Year:  2005        PMID: 15690665     DOI: 10.1007/s10350-004-0754-1

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  5 in total

1.  A Clinical Wide-Field Fluorescence Endoscopic Device for Molecular Imaging Demonstrating Cathepsin Protease Activity in Colon Cancer.

Authors:  Steven Sensarn; Cristina L Zavaleta; Ehud Segal; Stephan Rogalla; Wansik Lee; Sanjiv S Gambhir; Matthew Bogyo; Christopher H Contag
Journal:  Mol Imaging Biol       Date:  2016-12       Impact factor: 3.488

2.  Differential gene expression between flat adenoma and normal mucosa in the colon in a microarray analysis.

Authors:  Hiroto Kita; Yuichi Hikichi; Kouki Hikami; Koichi Tsuneyama; Zheng-Guo Cui; Hiroyuki Osawa; Hirohide Ohnishi; Hiroyuki Mutoh; Hiroko Hoshino; Christopher L Bowlus; Hironori Yamamoto; Kentaro Sugano
Journal:  J Gastroenterol       Date:  2006-12-08       Impact factor: 7.527

3.  Potential Factors Predicting Histopathologically Upgrade Discrepancies between Endoscopic Forceps Biopsy of the Colorectal Low-Grade Intraepithelial Neoplasia and Endoscopic Resection Specimens.

Authors:  Junbo Hong; Yining Wang; Jiangshan Deng; Miao Qi; Wei Zuo; Yuanzheng Hao; Anjiang Wang; Yi Tu; Shan Xu; Xiaodong Zhou; Xiaojiang Zhou; Guohua Li; Liang Zhu; Xu Shu; Yin Zhu; Nonghua Lv; Youxiang Chen
Journal:  Biomed Res Int       Date:  2022-06-06       Impact factor: 3.246

4.  Meta-Analysis of the Effect of Bowel Preparation on Adenoma Detection: Early Adenomas Affected Stronger than Advanced Adenomas.

Authors:  Michael C Sulz; Arne Kröger; Meher Prakash; Christine N Manser; Henriette Heinrich; Benjamin Misselwitz
Journal:  PLoS One       Date:  2016-06-03       Impact factor: 3.240

5.  Genetic and epigenetic alterations of Ras signalling pathway in colorectal neoplasia: analysis based on tumour clinicopathological features.

Authors:  K Harada; S Hiraoka; J Kato; J Horii; H Fujita; K Sakaguchi; Y Shiratori
Journal:  Br J Cancer       Date:  2007-10-09       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.